Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH)
Watchlist
93
Analysis
Health Care
•
China
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. manufactures and markets Chinese traditional medicines, including Pientzehuang, Pientzehuang capsules, Pientzehuang lozenge, cough syrup, and other related products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
19 Dec 2022 08:05
Northbound Flows (Dec 16th): CMB, Shanghai Intl Airport, Tongwei
We analyzed the Shanghai/Shenzhen Connect Scheme for last week and highlight flows for CMB, Shanghai Intl Airport, Tongwei.
Ke Yan, CFA, FRM
Follow
379 Views
Share
bearish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
21 Nov 2022 09:01
Zhangzhou Pientzehuang Pharmaceutical (600436.CH) - Disappointing Performance Is Just the Beginning
The investment logic of PienTzeHuang has changed, with more downside in valuation ahead. It's time to think about long logic from a broader...
Xinyao (Criss) Wang
Follow
347 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Nov 2022 09:33
China Healthcare Weekly (Nov4)-Opportunity in Culture Medium, European API, Long Logic of Investment
Culture medium will have a rapid growth period. Due to high costs, EU Pharma face difficulty in sustaining production.Mr Market begins to think...
Xinyao (Criss) Wang
Follow
240 Views
Share
bearish
•
Thematic (Sector/Industry)
•
12 Oct 2022 08:24
Russia-Ukraine War Episode 2 - The Balance Could Tilt Again and Its Impact on Healthcare Industry
The first episode of Russia-Ukraine war has ended and entered a new phase.As it becomes "small world war",the balance may tilt again. It's also a...
Xinyao (Criss) Wang
Follow
242 Views
Share
bearish
•
Thematic (Sector/Industry)
•
09 Oct 2022 08:58
China Healthcare Weekly (Oct.7)- Biotech Accept Reality, Import Substitution Logic, Consumer Medical
Although unwilling, biotech will face the harshest truth in 2023; Import substitution isn't good logic. Investors should know "when to join" &...
Xinyao (Criss) Wang
Follow
282 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x